Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
09/1995
09/28/1995CA2185788A1 Neuron promoter and uses
09/28/1995CA2184409A1 Recombinant adenoviruses coding for acidic fibroblast growth factor (afgf)
09/28/1995CA2184408A1 Recombinant adenoviruses for glial maturation factor beta (gmf-.beta.)
09/28/1995CA2184200A1 Recombinant viruses, preparation and use in genic therapy
09/28/1995CA2163251A1 4-p-fluorobenzoyl-1-piperidinyl-propoxy-chromen-4-one derivatives
09/27/1995EP0674004A1 MSRV1 virus and pathogenic and/or infections agent MSRV2 linked to multiple sclerosis, their nucleic components and their applications
09/27/1995EP0673934A1 Aminoalkyl benzothiazolinones, process for their preparation and pharmaceutical compositions containing them
09/27/1995EP0673933A1 Aminoalkyl benzoxazolinones and benzothiazolinones process for their preparation and compositions containing them
09/27/1995EP0673928A1 Novel N-(3,4-dichlorophenyl-propyl)-piperidine derivatives as selective human NK3-receptor antagonists
09/27/1995EP0673927A1 4-[2-indanyl-1-one]alkylpiperidines as anticholinergic agents
09/27/1995EP0673646A2 Use of Deoxypergualin in the manufacture of a medicament for the treatment of inflammatory-hyperresponsiveness diseases
09/27/1995EP0673378A1 New triazolopyrimidones, their preparation and their use.
09/27/1995EP0673377A1 New triazoloquinazolines, their production and their use.
09/27/1995EP0673375A1 Fused benzo compounds
09/27/1995EP0673374A1 Pharmaceutical composition containing bicyclic type compounds
09/27/1995EP0673373A1 Bicyclic compounds with pharmaceutical activity
09/27/1995EP0673371A1 Benzazepinone derivatives
09/27/1995EP0673368A1 Novel nicotinic acid esters
09/27/1995EP0673367A1 4-aminomethyl/thiomethyl/sulfonylmethyl-4-phenylpiperidines as tachykinin receptor antagonists
09/27/1995EP0673360A1 Aminomethylindans, -benzofuranes and -benzothiophenes
09/27/1995EP0673259A1 A method for transplanting cells into the brain and therapeutic uses therefor
09/27/1995EP0673252A1 Administration of oligonucleotides antisense to dopamine receptor mrna for diagnosis and treatment of neurological pathologies
09/27/1995EP0673249A1 Triazoloquinazolines for the treatment of diseases of the central nervous system
09/27/1995EP0673248A1 Potassium channel activators for use in therapy
09/27/1995EP0673245A1 Effervescent pharmaceutical composition containing ibuprofen and method for preparing same.
09/27/1995EP0510003B1 Piperidine and pyrrolidine derivatives
09/27/1995EP0311677B1 Cough/cold mixtures comprising non-sedating antihistamine drugs
09/27/1995CN1109099A A drink and manufacture thereof
09/27/1995CN1109057A 咪唑并哒嗪 Imidazopyridazine
09/27/1995CN1109054A Oxazolidin-2-one derivatives
09/27/1995CN1108947A Texiaosanchasan for curing prosopalgia and its preparation
09/27/1995CN1108934A Pharmaceutical compositions and usages
09/26/1995US5453446 Use of rasagiline or salts thereof
09/26/1995US5453428 Method and composition for the treatment of apathy-amotivation syndrome
09/26/1995US5453425 Risperidone oral formulation
09/26/1995US5453421 Antiarrythmia/antiischemic agents; treatment of cardiovascular disorders
09/26/1995US5453361 Method for producing biologically active human brain derived neurotrophic factor
09/26/1995CA1337128C Propanamine derivatives
09/26/1995CA1337123C Azacyclic carboxylic acid derivatives, their preparation and use
09/23/1995CA2145027A1 Aminoalkyl benzothiazolinones; process for preparing the same and pharmaceutical compositions containing them
09/23/1995CA2145026A1 Aminoalkyl benzoxazolinones and benzothiazolinones; process for preparing the same and pharmaceutical compositions containing them
09/21/1995WO1995025110A1 Heterocyclic compounds, their preparation and use
09/21/1995WO1995025102A1 Acid addition salts of 2,3,4,5-tetrahydro-1h-3-benzazepine compounds
09/21/1995WO1995025087A1 Cyclopropylacetonitrile derivatives, preparation thereof and use thereof as drugs
09/21/1995WO1995024918A1 Use of il-12 and il-12 antagonists in the treatment of autoimmune diseases
09/21/1995WO1995024903A1 The use of amino hydrogenated quinazoline compounds and derivatives thereof for abstaining from drug dependence
09/21/1995WO1995021612A3 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
09/21/1995CA2185670A1 Heterocyclic compounds, their preparation and use
09/21/1995CA2162916A1 Cyclopropylacetonitrile derivatives, preparation thereof and use thereof as drugs
09/20/1995EP0672666A2 Imidazodiazepins
09/20/1995EP0672416A1 Pharmaceutical composition comprising diamorphine
09/20/1995EP0672140A1 cDNAs ENCODING HUMAN NMDA-22A RECEPTOR SUBUNIT AND ISOFORMS OF THE HUMAN NMDA-R1 RECEPTOR SUBUNIT, TRANSFECTED CELL LINE EXPRESSING THEM
09/20/1995EP0672139A1 Novel polypeptides having opioid receptor activity, nucleic acids coding therefor and uses thereof
09/20/1995EP0672058A1 Calcium channel blocking polypeptides from heteropoda venatoria
09/20/1995EP0672055A1 Neuropeptide y antagonists
09/20/1995EP0672054A1 A novel molecule which inhibits neuropeptide tyrosine biological function
09/20/1995EP0672046A1 Spirofuranone derivatives and their use in the treatment of neurodegenerative disorders
09/20/1995EP0672041A1 Pharmacologically active pyridine derivatives and processes for the preparation thereof
09/20/1995EP0672032A1 Novel phenylethyl and phenylpropylamines
09/20/1995EP0671941A1 Bradykinin antagonists
09/20/1995EP0671915A1 Use of idazoxan and derivatives thereof in preparing a drug for treating parkinson's disease and its development
09/20/1995EP0671908A1 Pharmaceutical compositions comprising 5-ht 1? receptor agonists and absorption enhancers
09/20/1995EP0671879A1 Prevention of retinal injury and degeneration by specific factors
09/20/1995CN1108658A Galanthamine derivatives, a process for their preparation and their use as medicaments
09/20/1995CN1108657A Calanthamine derivatives, a process for their preparation and their use as medicaments
09/20/1995CN1108654A Methods of treating menstrual symtoms and compositions therefore
09/20/1995CN1108651A Substituted 1-naphthyl-3-pyrazolecarboxamides which are actie on neurotensin, their preparation and pharmaceutical compositions containing them
09/20/1995CN1029770C Controlled release bases for pharmaceuticals
09/19/1995US5451685 Substituted oxotremorine derivatives
09/19/1995US5451602 Cholecystokinin antagonists useful in the treatment of panic attcks
09/19/1995US5451588 Imidazole, triazole and tetrazole derivatives
09/19/1995US5451587 3-(2-propynyloxy)-1-azabicyclo(2.2.2)octane for treating alzheimer*s disease
09/19/1995US5451586 Substance P antagonist
09/19/1995CA1337073C 4 amino quinolines and naphthyridines, process for their preparation and their use as medicines
09/17/1995CA2144385A1 Treatment of alzheimer's disease employing inhibitors of cathepsin d
09/15/1995CA2144500A1 Pharmaceutical preparation
09/14/1995WO1995024422A1 Bradykinin antagonist peptides incorporating n-substituted glycines
09/14/1995WO1995024414A1 Fibroblast growth factor-10
09/14/1995WO1995024389A1 Indole derivatives as cck receptor antagonists
09/14/1995WO1995024381A1 Cyano compounds and preparations thereof
09/14/1995WO1995024191A1 8-substituted tetrahydro-beta-carbolines
09/14/1995CA2185235A1 8-substituted tetrahydro-beta-carbolines
09/14/1995CA2184824A1 Bradykinin antagonist peptides incorporating n-substituted glycines
09/14/1995CA2183961A1 Fibroblast growth factor-10
09/13/1995EP0671397A1 Alkylaminoindanes compounds, processes for their preparation and pharmaceutical compositions containing them
09/13/1995EP0671388A1 (Pyrrolidinyl)phenyl carbamates and intermediate compounds, processes for their preparation and their use as medicaments
09/13/1995EP0671173A1 Use of a tricyclic derivative for producing a medicament for the treatment of cognitive and memory disorders
09/13/1995EP0670837A1 METHOD OF PREPARING -g(b)-CARBOLINES.
09/13/1995EP0670826A1 Fatty acid derivatives and pharmaceutical compositions containing them
09/13/1995EP0670727A1 Compounds that inhibit t cell proliferation and methods using the same
09/13/1995EP0670713A1 A pharmaceutical formulation
09/13/1995CN1108255A Methods of inhibiting the symtoms of premenstrual syndrome/late luteal phase dysphoric disorder
09/13/1995CN1108240A Excitatory amino acid receptor antagonists
09/13/1995CN1108098A Methods of inhibiting alzheimer's disease
09/13/1995CN1108096A Non-peptide tachykinin receptor antagonists
09/13/1995CN1108093A Methods for inhibiting vasomotor symptons and attending psychological disturbances surrounding post-menopausal syndrome
09/12/1995US5449813 Phenylethanolamino- and phenylethanolaminomethyl-tetralines, process for the preparation thereof, intermediates in said process and pharmaceutical compositions containing them
09/12/1995US5449787 N,N'-disubstituted amide derivatives
09/12/1995US5449692 Substituted (arylalkylaminobenzyl) aminopropionamide derivatives and process for their preparation
09/12/1995US5449690 Naphthylethylureas and naphthylethylthioureas